BenefitsPRO: Employee Benefits News, Trends & Sales Tips

500 pharma and biotech CEOs call for reversal of abortion pill ban

By Alan Goforth

Pfizer's CEO was the first major pharmaceutical company leader to add his name to the open letter, written after a Texas federal judge banned the use of the FDA-approved abortion pill mifepristone.

Read Story

News

Access to abortion pill in limbo, after conflicting federal court rulings

News

Employees see vision benefits as critical but often leave them on the table, survey finds

Recommended Just For You

News Stories

April 07, 2023

Xanax and Adderall's 'secret drug limits' due to opioid settlement with top 3 distributors

The limits stem from an opioid settlement with AmerisourceBergen, Cardinal Health and McKesson that flag and sometimes block controlled substances – and patients with anxiety and sleep disorder are caught in the crosshairs.

Read

April 07, 2023

After SECURE 2.0, State lawmakers are considering a range of bills that could affect the benefits field

"Clear employment law trends for 2023 have emerged. Some of the more significant trends reflect the country's social and political atmosphere," the authors of the study wrote.

Read

April 06, 2023

Industry reacts with caution on Braidwood vs. Becerra ruling; patient, provider groups are worried

The consensus among experts was that it will take at least another year to see where the ruling stands, as likely appeals play out.

Read

April 06, 2023

ACA premiums rise 3.4% in 2023, as rate of new insurers slowed

Premiums are greatly affected by the number of insurers competing in the rating region: the more insurers, the lower the benchmark premiums, according to the Robert Wood Johnson Foundation report.

Read

April 05, 2023

Missing retirement plan participants? DOL ramping up efforts to locate lost employees

The DOL is asking Congress for $5 million to establish a dedicated program, led by the Employee Benefits Security Administration, which recovered more than $1.5 billion in lost benefits for missing participants in 2021.

Read

April 05, 2023

Uber Health launches same-day prescription drug delivery

Uber's health care arm, whose clients include health care providers and insurance plans, will now manage drug delivery from any pharmacy in their service area by partnering with tech platform ScriptDrop.

Read

April 05, 2023

Bipartisan bill would ensure continued access to telehealth services

The Telehealth Expansion Act would make permanent a waiver created by the CARES Act to allow workers with HSAs to access telehealth services without first having to meet their deductible.

Read

‹ ‹ PREV 369 370 371 ... 740 › NEXT ›

News

Top News Stories

500 pharma and biotech CEOs call for reversal of abortion pill ban

Access to abortion pill in limbo, after conflicting federal court rulings

Employees see vision benefits as critical but often leave them on the table, survey finds

Recommended Just For You

News Stories

Xanax and Adderall's 'secret drug limits' due to opioid settlement with top 3 distributors

After SECURE 2.0, State lawmakers are considering a range of bills that could affect the benefits field

Industry reacts with caution on Braidwood vs. Becerra ruling; patient, provider groups are worried

ACA premiums rise 3.4% in 2023, as rate of new insurers slowed

Missing retirement plan participants? DOL ramping up efforts to locate lost employees

Uber Health launches same-day prescription drug delivery

Bipartisan bill would ensure continued access to telehealth services